Warning: fopen(/home/virtual/enm-kes/journal/upload/ip_log/ip_log_2024-11.txt): failed to open stream: Permission denied in /home/virtual/lib/view_data.php on line 100 Warning: fwrite() expects parameter 1 to be resource, boolean given in /home/virtual/lib/view_data.php on line 101
1Division of Endocrinology and Metabolism, Department of Internal Medicine, Dong-A Medical Center, Dong-A University College of Medicine, Busan, Korea.
2Division of Endocrinology and Metabolism, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
3Division of Endocrinology and Metabolism, Department of Internal Medicine, Samsung Changwon Hospital, Sungkyunkwan University School of Medicine, Changwon, Korea.
4Department of Preventive Medicine, Ajou University School of Medicine, Suwon, Korea.
Copyright © 2014 Korean Endocrine Society
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Values are expressed as mean±SD or number (%).
BMI, body mass index; HbA1c, glycated hemoglobin; SBP, systolic blood pressure; DBP, diastolic blood pressure; TC, total cholesterol; TG, triglycerides; HDL-C, high density lipoprotein cholesterol; LDL-C, low density lipoprotein cholesterol; HOMA-IR, homeostasis model of assessment-insulin resistance.
aHOMA-IR=[fasting plasma glucose (mmol/L)×fasting plasma insulin]/22.5.
Values are expressed as number (%). Adjusted for age, smoking status, low density lipoprotein cholesterol, and homeostasis model of assessment-insulin resistance.
MetS, metabolic syndrome; HR, hazard ratio; CI, confidence interval; CVD, cardiovascular disease; CHD, coronary heart disease.
aCVD was defined as occurrence of CHD and/or stroke.
Values are expressed as hazard ratio (95% confidence interval). Adjusted for age, smoking status, low density lipoprotein cholesterol, homeostasis model of assessment-insulin resistance, and metabolic syndrome components.
CVD, cardiovascular disease; CHD, coronary heart disease; TG, triglycerides; HDL, high density lipoprotein cholesterol.
aP<0.05; bP<0.001.
Values are expressed as mean±SD or number (%). BMI, body mass index; HbA1c, glycated hemoglobin; SBP, systolic blood pressure; DBP, diastolic blood pressure; TC, total cholesterol; TG, triglycerides; HDL-C, high density lipoprotein cholesterol; LDL-C, low density lipoprotein cholesterol; HOMA-IR, homeostasis model of assessment-insulin resistance. aHOMA-IR=[fasting plasma glucose (mmol/L)×fasting plasma insulin]/22.5.
Values are expressed as number (%). Adjusted for age, smoking status, low density lipoprotein cholesterol, and homeostasis model of assessment-insulin resistance. MetS, metabolic syndrome; HR, hazard ratio; CI, confidence interval; CVD, cardiovascular disease; CHD, coronary heart disease. aCVD was defined as occurrence of CHD and/or stroke.
Values are expressed as hazard ratio (95% confidence interval). Adjusted for age, smoking status, low density lipoprotein cholesterol, homeostasis model of assessment-insulin resistance, and metabolic syndrome components. CVD, cardiovascular disease; CHD, coronary heart disease; TG, triglycerides; HDL, high density lipoprotein cholesterol. a
Adjusted for age, smoking status, low density lipoprotein cholesterol, and homeostasis model of assessment-insulin resistance. HR, hazard ratio; CI, confidence interval.